Navigation Links
Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems, LLC Cites Broad Applications of its 2013 Harvest of Uniquely Valuable Hemp Oil

SAN DIEGO, Dec. 12, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to update its shareholders on the status of its portfolio company, PhytoSPHERE Systems, LLC and product applications for it's 2013 harvest.  PhytoSPHERE is the world's leading cannabinoid based biotechnology company.  Its unique self-contained hemp cultivation and hemp oil processing facilities produce superior raw ingredients for neutraceutical markets.

As a result, this season's harvest of hemp oil has, for the first time, put the Company in a position to develop broadly applicable raw ingredients.  In addition to providing these raw ingredients to its subsidiaries for their products, the company is preparing to distribute raw ingredients to other manufacturers for a vast array of consumer product applications.

The raw CBD ingredients in our hemp oil can be formulated with or added to existing and newly developed products in foods, dietary supplements and cosmetics.  The Company is working with formulators to integrate the hemp oil with a variety of generally accepted beneficial dietary ingredients to develop uniquely effective over the counter products.  These products are expected to be highly sought after by health conscious consumers. 

The CBD market is presently in its infancy with exciting possibilities ahead.  The "marijuana community" has recently embraced CBD as the next great thing in patient health and wellness—it is only a matter of time before the general populace discovers similar benefits.  "We are very proud about the many innovative products using our hemp oil ingredients, that will be delivered to health conscious consumers in the coming year," says Ted Caligiuri, President/CEO of Medical Marijuana, Inc.

Unique Growing Process

The company cultivates thousands of acres of industrial hemp in special microclimates located in various countries abroad.  MJNA plans to increase the amount of acreage under cultivation, as demand for its specialty hemp oil products continues to grow for existing and emerging products.

PhytoSPHERE manages the entire growth and manufacturing operation starting from the initial planting of specialty cultivars through the monitoring of the growth cycle to harvesting the crops and producing the end products.  In these unique environments, PhytoSPHERE raises hemp cultivars with high levels of cannabinoid (CBD), which are then processed into raw hemp oil using the company's proprietary processes.

PhytoSPHERE's extremely efficient growth, packaging and extraction technologies provide compact, safe, pollutant-free facilities that allow for the following:

  • Completely controlled cultivation environment
  • Greatly increased plant yields with strong, compact, multi-directional growth that significantly exceed traditional methods
  • Reduced per-unit costs compared to traditional methods by eliminating the use of pesticides, fungicides and herbicides
  • Production of Pharmaceutical grade extracts
  • Establishment of antibacterial environments and packaging systems
  • Controlled post-production processing with proprietary standardization methods

History and Current Market

Hemp extracts have been used for medicinal purposes dating back to the ancient Chinese Pharmacopoeia, estimated at year 5,000 BC. Cannabis and hemp products were considered medicines and readily listed in the US Pharmacopoeia from 1850 through the early 1940's.  Marijuana was banned from being possessed in the United States in 1937. 

When derived from hemp stalk or seed, CBD is considered a food nutrient or dietary supplement, delivering the benefits of cannabinoids without the psychoactive/euphoric effects of THC.  There are over 400 cannabinoids found in marijuana/hemp.  Our present over-the-counter products contain industrial hemp whole plant extract from seed and stalk and from isolated strains or "cultivars" of hemp that provide significant quantities and concentrations of CBD. 

Recent scientific research has shown that humans (and all mammals) have an affinity for these cannabinoids.  Mammalian cells contain two known receptor sites on cell membranes for various cannabinoid compounds.  Humans can supplement any potential deficiencies in their endo-cannabinoid systems with plant-derived phyto-cannabinoids, such as our CBD products. 

CBDs have been shown to carry huge medical benefits for a variety of physical and mental maladies/illnesses, including musculo-skeletal pain relief, assisting with multiple sclerosis muscle spasticity management, diabetes, schizophrenia and even metastatic cancer.  For more information on the health benefits of CBD, go here:

The remarkable health benefits of CBDs are currently delivered via tinctures, gums, topical applications/balms and oral drops through products developed through our subsidiary companies. These products provide a strong platform for the Company to expand its presence through further development and tap the vast market potential that currently exists.

Expanding Markets

PhytoSPHERE Systems has documented over 200 industrial hemp varieties and has identified specific ones with the highest levels of CBD for further development and production. Using tissue cultures, PhystoSPHERE produces plants that have a higher likelihood of success because of their genetic purity and identical attributes.  This allows for a consistently high quality plant, which in turn delivers a consistent end product. 

The combination of superior technology, proprietary and patented processes, genetically consistent products and tissue culture-based plants will give us the ability to produce the cleanest and highest quality ingredients for consumer/food grade products. 

Significantly, however, it will also position us to provide superior pharmaceutical grade extracts and compounds.  While we are currently poised to expand in the CBD market, we realize the full potential in expanding our portfolio beyond hemp-based products.  As legislations continue to change at the state and national levels—not to mention internationally—we look forward to vastly increasing our offerings with THC based products.  In Colorado alone, the legal medical marijuana market is presently a $46 million annual industry.  Washington state's Office of Financial Management recently mentioned their state-wide "fully functioning marijuana market" could result in $1.021 billion in gross in-state sales, given both medical and recreational usage.  Further, the Office stated that the national market, so extrapolated, could result in a US marijuana marketplace of $46.42 billion.  Link:  This estimation is considering just actual marijuana sales, not peripheral industries and those additional revenues.  We look forward to embracing this potential.

Medical Marijuana, Inc., with its subsidiary PhytoSPHERE systems, is proud to be at the forefront of this market and to offer a streamlined, all-encompassing company in which its shareholders may participate in our multiple streams of future growth. 

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.  We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website:


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.  This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:

Medical Marijuana, Inc.
Toll Free:  888-OTC-MJNA (888-682-6562)

Investor Relations Contact:

Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
AIM: SmallCapVoice7



SOURCE Medical Marijuana, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Winner Medical Announces Closing of Going Private Transaction
2. Brolex C SAFE cesarean section safety device receives top scores, rated a MUST HAVE medical device for performing c/sections.
3. Sequent Medical, Inc. führt VIA-Mikrokatheter ein
4. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
5. Sequent Medical, Inc. lance le microcathéter VIA
6. Sequent Medical, Inc. lanza el microcatéter VIA
7. Sequent Medical, Inc. Launches VIA Microcatheter
8. Vasomedical Common Stock Commences Trading on the OTCBB
9. Frost & Sullivan: Appropriate Channel Partners Vital in the Highly Fragmented Medical Devices Distribution Market in VITSK
10. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
11. Medical Marijuana Inc. and the Dixie Elixirs and Edibles Brand will be on Fox News Geraldo at Large on December 8, 2012.
Post Your Comments:
(Date:10/9/2015)... October 9, 2015 ... sich einer Kolonoskopie im Rahmen eines Screenings, ... Die NOCT-Studie bewertete auch die Compliance, Sicherheit, ... ® ) an erwachsenen Patienten vergleicht, ... Screenings, einer beobachtenden oder einer diagnostischen Kolonoskopie ...
(Date:10/9/2015)... -- --> --> ... of an Intellectual Property & Subsidiary Assignment and an Assignment & Assumption ... Corporation, related party, and a majority holder of 88% ... --> These agreements were executed as part of ... and Development components shall now be separate from the ...
(Date:10/9/2015)... India , October 9, 2015 ... --> The report ... market and overall status of the ... of guidance and direction for companies ... . ...
Breaking Medicine Technology:
... /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and ... Shareholder Meeting to the 26th floor, Conference Room E ... (EDT). Shareholders will be admitted beginning at 9:30 am. ...
... 2011 Bacterin International Holdings, Inc. (NYSE Amex: ... that it has scheduled a conference call ... to discuss the Company,s financial results for its fourth ...   Bacterin International Holdings, Inc. intends to issue its earnings ...
Cached Medicine Technology:
(Date:10/9/2015)... ... 09, 2015 , ... The American Osteopathic Foundation (AOF) has ... Education J. Michael Finley, DO, as the recipient of the 2015 W. Douglas ... on graduate medical education opportunities for osteopathic residents, and his dedication to promoting ...
(Date:10/9/2015)... ... October 09, 2015 , ... A new health tool that helps identify ... available online ( ) – just in time for the cold and flu ... October. However, for many in the U.S., the real start of cold/flu season is ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... promotion on Invisalign, the orthodontic system that uses clear, plastic aligners. This alternative ... invisible against the teeth, which allow patients to complete treatment in privacy. Additionally, ...
(Date:10/9/2015)... Washington, DC (PRWEB) , ... October 09, 2015 , ... ... agreement from the US Centers for Disease Control and Prevention (CDC) to improve the ... 14 years that AAFA has been awarded a project by the CDC and allows ...
(Date:10/9/2015)... Ohio (PRWEB) , ... October 09, 2015 , ... ... United States, is welcoming individuals from all walks of life to save money ... the set price of $25 per month per medication, individuals and families can ...
Breaking Medicine News(10 mins):
... 12 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today ... on February 19, 2009, and will host a conference call to ... Eastern Time. , , , Date: ... Time, Conference call access:, Internet: ...
... Pamper Tired TootsiesBETHESDA, Md., Feb. 12 Valentine,s Day marks ... men and women. While the old adage "a way to ... true, another body part is gaining affection from both sexes ... (APMA) survey revealed 84 percent of women are embarrassed about ...
... MediCom Worldwide, Inc., an accredited provider of continuing medical ... of an online repository of resources and education on ... of health care practitioners.The goal of Managing ... to provide an extensive array of programs to support ...
... Scientists studying an inherited condition resulting in blindness and ... affect both eye function and normal tooth development. ... the formation of teeth and eyes has been uncovered ... in two families living in a village in the ...
... a key role in the prevention and treatment of ... Endothelial cells line the blood vessels and are critical ... , Researchers at the Centenary Institute have discovered ... cells. , Professor Jenny Gamble, Head of ...
... research will focus increasingly on electronic data, with less ... long term trend emerged at a recent conference on ... dealt with the challenges posed by the growing scale ... But in the more immediate future biological specimens will ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: